Infectious Th1 and Th2 autoimmunity in diabetes-prone mice

Immunological Reviews

Volumn 164, Issue , 1998, Pages 119-127

  Tian, Jide ^a   Olcott, Angelica P ^a   Hanssen, Lorraine R ^a   Zekzer, Dan ^a   Middleton, Blake ^a   Kaufman, Daniel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; HUMORAL IMMUNITY; INSULITIS; MORBIDITY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 2; EPITOPE MAPPING; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; TH1 CELLS; TH2 CELLS;

EID: 0031785620     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01214.x     Document Type: Article

References (51)

1. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994;15:516-542.
2. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996;85:291-297.
3. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997;7:727-738.
4. Palmer JP. Predicting IDDM: use of humoral immune markers. Diabetes Reviews 1993;1:104-115.
5. Kaufman DL, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
6. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993;366:72-75.
7. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-208.
8. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-1788.
9. Sarvetnick N, et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990;346:844-847.
10. Heath WR, et al. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992;359:547-549.
11. Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes 1996;45:1299-1305.
12. Ridgway WM, Fasso M, Lanctot A, Garvey C, Fathman CG. Breaking self-tolerance in nonobese diabetic mice. J Exp Med 1996;183:1657-1662.
13. Pugliese A, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15:293-297.
14. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;171:1728-1730.
15. Tian J, Lehmann PV, Kaufman DL. Determinant spreading of T helper 2 (TH2) responses to pancreatic islet autoantigens. J Exp Med 1997;186:2039-2044.
16. Tian J, et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 1996;2:1348-1353.
17. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
18. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994;6:458-466.
19. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-285.
20. Reiner SL, Seder RA. T helper cell differentiation in immune response. Curr Opin Immunol 1995;7:360-366.
21. Mamula MJ, Janeway CA Jr. Do B cells drive the diversification of immune responses? Immunol Today 1993;14:151-152.
22. Tian J, et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-1567.
23. Argyris BF. Adoptive tolerance; transfer of the tolerant state. J Exp Med 1962;90:29-34.
24. Qin S, et al. "Infectious" transplantation tolerance. Science 1993;259:974-977.
25. Genain CP, et al. Late complications of immune deviation therapy in a nonhuman primate. Science 1996;274:2054-2057.
26. Harrison LC, et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes [see comments]. Lancet 1993;341:1365-1369.
27. Thai AC, Eisenbarth GS. Natural history of IDDM. Diabetes Reviews 1993;1:1-14.
28. Julia V, Rassoulzadegan M, Glaichenhaus N. Resistance to Leishmonia major induced by tolerance to a single antigen. Science 1996;274:421-423.
29. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
30. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
31. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990;63:1249-1256.
32. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today 1994;15:362-366.
33. Kuchroo VK, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-718.
34. Robadey C, Wallny HJ, Demotz S. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116. Eur J Immunol 1996;26:1656-1659.
35. Butz EA, Bevan MJ. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J Immunol 1998;160:2139-2144.
36. Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J Immunol 1998;160:1555-1564.
37. Rossi-Bergmann B, Muller I, Godinho EB. TH1 and TH2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis. Infect Immun 1993;61:2266-2269.
38. Stockinger B, Zal T, Zal A, Gray D. B cells solicit their own help from T cells. J Exp Med 1996;183:891-899.
39. Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL. IL-4 induces Fas resistance in B cells. J Immunol 1996;157:2749-2753.
40. Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 1994;180:2089-2099.
41. Oehen SU, Ohashi PS, Burki K, Hengartner H, Zinkernagel RM, Aichele P. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell Immunol 1994;158:342-352.
42. Von Herrath MG, Dockter J, Oldstone MB. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994;1:231-242.
43. Akkaraju S, Ho WY, Leong D, Canaan K, Davis MM, Goodnow CC. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997;7:255-271.
44. Cibotti R, et al. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci USA 1992;89:416-420.
45. Egwuagu CU, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997;159:3109-3112.
46. Elias D, Cohen IR. Peptide therapy for diabetes in NOD mice. Lancet 1994;343:704-706.
47. Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 1996;157:4230-4238.
48. Von Herrath MG, Dyrberg T, Oldstone MB. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996;98:1324-1331.
49. Förster I, Hirose R, Arbeit JM, Clausen BE, Hanahan D. Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen. Immunity 1995;2:573-585.
50. Mueller R, Bradley LM, Krahl T, Sarvetnick N. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 1997;7:411-418.
51. Elias D, Reshef T, Birk OS, van der Zee R, Walker MD, Cohen IR. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991;88:3088-3091.